BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Jasper Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 09:41 am Sale | 2023-12-31 | 13G | Jasper Therapeutics, Inc. JSPR | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -990,000 (Position Closed) | Filing |
| 2023-02-06 4:43 pm Purchase | 2023-01-25 | 13G | Jasper Therapeutics, Inc. JSPR | BIOTECHNOLOGY VALUE FUND L P | 990,000 9.100% | 990,000 (New Position) | Filing |